Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- Conditions
- Severe Aplastic Anemia
- Interventions
- First Posted Date
- 2020-03-11
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 80
- Registration Number
- NCT04304820
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
- Conditions
- ObesityCardiometabolic DiseasesAtherosclerotic Cardiovascular DiseaseDyslipidemiaPsoriasis
- Interventions
- Dietary Supplement: NiagenOther: Placebo
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2023-12-27
- Target Recruit Count
- 29
- Registration Number
- NCT04271735
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2025-04-27
- Target Recruit Count
- 15
- Registration Number
- NCT04269889
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2025-05-11
- Target Recruit Count
- 64
- Registration Number
- NCT04216342
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Conditions
- Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Leukemia (SLL)
- Interventions
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2022-03-09
- Target Recruit Count
- 3
- Registration Number
- NCT04209621
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
CHIP/CCUS Natural History Protocol
- Conditions
- Clonal Cytopenia of Undetermined SignificanceClonal Hematopoiesis of Indeterminate Potential
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2025-05-01
- Target Recruit Count
- 306
- Registration Number
- NCT04102423
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women
- Conditions
- Cardiovascular (CV) Risk
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 250
- Registration Number
- NCT04014348
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
- Conditions
- Myeloid Chimerism
- Interventions
- Device: CliniMACS CD34 Reagent
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2025-04-11
- Target Recruit Count
- 32
- Registration Number
- NCT04008368
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- Drug: During Venetoclax
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2025-04-16
- Target Recruit Count
- 75
- Registration Number
- NCT03986034
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2024-10-11
- Target Recruit Count
- 70
- Registration Number
- NCT03958643
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States